204 related articles for article (PubMed ID: 8665507)
1. Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells.
Pizer ES; Jackisch C; Wood FD; Pasternack GR; Davidson NE; Kuhajda FP
Cancer Res; 1996 Jun; 56(12):2745-7. PubMed ID: 8665507
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer.
Pizer ES; Wood FD; Heine HS; Romantsev FE; Pasternack GR; Kuhajda FP
Cancer Res; 1996 Mar; 56(6):1189-93. PubMed ID: 8640795
[TBL] [Abstract][Full Text] [Related]
3. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
4. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
Menendez JA; Lupu R
Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
[TBL] [Abstract][Full Text] [Related]
5. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts.
Pizer ES; Thupari J; Han WF; Pinn ML; Chrest FJ; Frehywot GL; Townsend CA; Kuhajda FP
Cancer Res; 2000 Jan; 60(2):213-8. PubMed ID: 10667561
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines.
Pizer ES; Chrest FJ; DiGiuseppe JA; Han WF
Cancer Res; 1998 Oct; 58(20):4611-5. PubMed ID: 9788612
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity.
Thupari JN; Pinn ML; Kuhajda FP
Biochem Biophys Res Commun; 2001 Jul; 285(2):217-23. PubMed ID: 11444828
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis of androgen-independent prostate cell line induced by inhibition of fatty acid synthesis.
Furuya Y; Akimoto S; Yasuda K; Ito H
Anticancer Res; 1997; 17(6D):4589-93. PubMed ID: 9494573
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
Menendez JA; Colomer R; Lupu R
Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells.
Vazquez-Martin A; Ropero S; Brunet J; Colomer R; Menendez JA
Oncol Rep; 2007 Oct; 18(4):973-80. PubMed ID: 17786362
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of fatty acid metabolism in oral squamous cell carcinoma.
Zhang Y; Guo C; Yu G
Int J Oral Maxillofac Surg; 2005 Jan; 34(1):78-81. PubMed ID: 15617971
[TBL] [Abstract][Full Text] [Related]
12. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells.
Pizer ES; Wood FD; Pasternack GR; Kuhajda FP
Cancer Res; 1996 Feb; 56(4):745-51. PubMed ID: 8631008
[TBL] [Abstract][Full Text] [Related]
14. [Proliferation inhibition and apoptosis induction of K562 cells by fatty acid synthase inhibitor--cerulenin].
Chen B; Huang P; Dai Z; Lin G
Zhonghua Xue Ye Xue Za Zhi; 2000 May; 21(5):244-6. PubMed ID: 11876988
[TBL] [Abstract][Full Text] [Related]
15. Increased fatty acid synthase is a therapeutic target in mesothelioma.
Gabrielson EW; Pinn ML; Testa JR; Kuhajda FP
Clin Cancer Res; 2001 Jan; 7(1):153-7. PubMed ID: 11205903
[TBL] [Abstract][Full Text] [Related]
16. Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase.
Zeng L; Biernacka KM; Holly JM; Jarrett C; Morrison AA; Morgan A; Winters ZE; Foulstone EJ; Shield JP; Perks CM
Endocr Relat Cancer; 2010 Jun; 17(2):539-51. PubMed ID: 20356977
[TBL] [Abstract][Full Text] [Related]
17. Triclosan inhibits enoyl-reductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast cancer cells.
Liu B; Wang Y; Fillgrove KL; Anderson VE
Cancer Chemother Pharmacol; 2002 Mar; 49(3):187-93. PubMed ID: 11935210
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
Zhou W; Simpson PJ; McFadden JM; Townsend CA; Medghalchi SM; Vadlamudi A; Pinn ML; Ronnett GV; Kuhajda FP
Cancer Res; 2003 Nov; 63(21):7330-7. PubMed ID: 14612531
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.
Zhou W; Han WF; Landree LE; Thupari JN; Pinn ML; Bililign T; Kim EK; Vadlamudi A; Medghalchi SM; El Meskini R; Ronnett GV; Townsend CA; Kuhajda FP
Cancer Res; 2007 Apr; 67(7):2964-71. PubMed ID: 17409402
[TBL] [Abstract][Full Text] [Related]
20. Characterization and inhibition of fatty acid synthase in pediatric tumor cell lines.
Slade RF; Hunt DA; Pochet MM; Venema VJ; Hennigar RA
Anticancer Res; 2003; 23(2B):1235-43. PubMed ID: 12820377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]